Articles by tag: drug-development

Breakthrough technologies in oncology: shift to PROTAC and CAR-T

Nature records a paradigm shift: oncology moves from inhibitors to PROTAC and cell therapy. Find out who wins in the new race and what awaits the market.

Unified FDA and EMA Rules for AI in Pharma

FDA and EMA approved 10 GxP principles for AI in drug development. Learn how the new rules will change the industry and how to prepare for them.

FDA will approve subcutaneous Lecanemab in August 2026

Analysis of the FDA decision postponement for Leqembi IQLIK to August 24: why this is a signal for approval, not a delay. Benefits for Alzheimer's patients and market forecast. Read key takeaways.

Big Pharma Mergers: $84 Billion in Deals in a Quarter

The $300 Billion Patent Cliff Drove Big Pharma to Spend $84 Billion on Biotech Deals in Q1. Find Out Which Companies Are Buying and Why.